ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Kidney Fibrosis Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-15M13268
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Kidney Fibrosis Drugs Market Research Report 2023
BUY CHAPTERS

Global Kidney Fibrosis Drugs Market Research Report 2025

Code: QYRE-Auto-15M13268
Report
May 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck and Co.
Galectin Therapeutics
Pfizer Inc
InterMune
La Jolla Pharmaceutical Company
F. Hoffman-La Roche
ProMetic Life Sciences Inc
BioLine Rx
Genzyme Corporation

Kidney Fibrosis Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Kidney Fibrosis Drugs Market

Kidney Fibrosis Drugs Market

The global market for Kidney Fibrosis Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Kidney Fibrosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Fibrosis Drugs.
The Kidney Fibrosis Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Kidney Fibrosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Kidney Fibrosis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Kidney Fibrosis Drugs Market Report

Report Metric Details
Report Name Kidney Fibrosis Drugs Market
CAGR 5%
Segment by Type
  • Angiotensin Converting Enzyme (ACE) Inhibitors
  • Pirfenidone
  • Renin Inhibitors
  • Angiotensin II Receptor Blockers (ARBs)
  • Vasopeptidase Inhibitors
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck and Co, Galectin Therapeutics, Pfizer Inc, InterMune Inc, La Jolla Pharmaceutical Company, BioLine Rx, F. Hoffman-La Roche, ProMetic Life-Sciences Inc, Genzyme Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Kidney Fibrosis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Kidney Fibrosis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Kidney Fibrosis Drugs Market report?

Ans: The main players in the Kidney Fibrosis Drugs Market are Merck and Co, Galectin Therapeutics, Pfizer Inc, InterMune Inc, La Jolla Pharmaceutical Company, BioLine Rx, F. Hoffman-La Roche, ProMetic Life-Sciences Inc, Genzyme Corporation

What are the Application segmentation covered in the Kidney Fibrosis Drugs Market report?

Ans: The Applications covered in the Kidney Fibrosis Drugs Market report are Chronic Kidney Diseases, Kidney Cancer Treatment, Others

What are the Type segmentation covered in the Kidney Fibrosis Drugs Market report?

Ans: The Types covered in the Kidney Fibrosis Drugs Market report are Angiotensin Converting Enzyme (ACE) Inhibitors, Pirfenidone, Renin Inhibitors, Angiotensin II Receptor Blockers (ARBs), Vasopeptidase Inhibitors

Recommended Reports

Kidney Diseases Drugs

Fibrosis Related Markets

Urinary and Renal Therapies

1 Kidney Fibrosis Drugs Market Overview
1.1 Product Definition
1.2 Kidney Fibrosis Drugs by Type
1.2.1 Global Kidney Fibrosis Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Angiotensin Converting Enzyme (ACE) Inhibitors
1.2.3 Pirfenidone
1.2.4 Renin Inhibitors
1.2.5 Angiotensin II Receptor Blockers (ARBs)
1.2.6 Vasopeptidase Inhibitors
1.3 Kidney Fibrosis Drugs by Application
1.3.1 Global Kidney Fibrosis Drugs Market Value by Application (2024 VS 2031)
1.3.2 Chronic Kidney Diseases
1.3.3 Kidney Cancer Treatment
1.3.4 Others
1.4 Global Kidney Fibrosis Drugs Market Size Estimates and Forecasts
1.4.1 Global Kidney Fibrosis Drugs Revenue 2020-2031
1.4.2 Global Kidney Fibrosis Drugs Sales 2020-2031
1.4.3 Global Kidney Fibrosis Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Kidney Fibrosis Drugs Market Competition by Manufacturers
2.1 Global Kidney Fibrosis Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Kidney Fibrosis Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Kidney Fibrosis Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Kidney Fibrosis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Kidney Fibrosis Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Kidney Fibrosis Drugs, Product Type & Application
2.7 Global Key Manufacturers of Kidney Fibrosis Drugs, Date of Enter into This Industry
2.8 Global Kidney Fibrosis Drugs Market Competitive Situation and Trends
2.8.1 Global Kidney Fibrosis Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Kidney Fibrosis Drugs Players Market Share by Revenue
2.8.3 Global Kidney Fibrosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Kidney Fibrosis Drugs Market Scenario by Region
3.1 Global Kidney Fibrosis Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Kidney Fibrosis Drugs Sales by Region: 2020-2031
3.2.1 Global Kidney Fibrosis Drugs Sales by Region: 2020-2025
3.2.2 Global Kidney Fibrosis Drugs Sales by Region: 2026-2031
3.3 Global Kidney Fibrosis Drugs Revenue by Region: 2020-2031
3.3.1 Global Kidney Fibrosis Drugs Revenue by Region: 2020-2025
3.3.2 Global Kidney Fibrosis Drugs Revenue by Region: 2026-2031
3.4 North America Kidney Fibrosis Drugs Market Facts & Figures by Country
3.4.1 North America Kidney Fibrosis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Kidney Fibrosis Drugs Sales by Country (2020-2031)
3.4.3 North America Kidney Fibrosis Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Kidney Fibrosis Drugs Market Facts & Figures by Country
3.5.1 Europe Kidney Fibrosis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Kidney Fibrosis Drugs Sales by Country (2020-2031)
3.5.3 Europe Kidney Fibrosis Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Kidney Fibrosis Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Kidney Fibrosis Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Kidney Fibrosis Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Kidney Fibrosis Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Kidney Fibrosis Drugs Market Facts & Figures by Country
3.7.1 Latin America Kidney Fibrosis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Kidney Fibrosis Drugs Sales by Country (2020-2031)
3.7.3 Latin America Kidney Fibrosis Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Kidney Fibrosis Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Kidney Fibrosis Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Kidney Fibrosis Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Kidney Fibrosis Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Kidney Fibrosis Drugs Sales by Type (2020-2031)
4.1.1 Global Kidney Fibrosis Drugs Sales by Type (2020-2025)
4.1.2 Global Kidney Fibrosis Drugs Sales by Type (2026-2031)
4.1.3 Global Kidney Fibrosis Drugs Sales Market Share by Type (2020-2031)
4.2 Global Kidney Fibrosis Drugs Revenue by Type (2020-2031)
4.2.1 Global Kidney Fibrosis Drugs Revenue by Type (2020-2025)
4.2.2 Global Kidney Fibrosis Drugs Revenue by Type (2026-2031)
4.2.3 Global Kidney Fibrosis Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Kidney Fibrosis Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Kidney Fibrosis Drugs Sales by Application (2020-2031)
5.1.1 Global Kidney Fibrosis Drugs Sales by Application (2020-2025)
5.1.2 Global Kidney Fibrosis Drugs Sales by Application (2026-2031)
5.1.3 Global Kidney Fibrosis Drugs Sales Market Share by Application (2020-2031)
5.2 Global Kidney Fibrosis Drugs Revenue by Application (2020-2031)
5.2.1 Global Kidney Fibrosis Drugs Revenue by Application (2020-2025)
5.2.2 Global Kidney Fibrosis Drugs Revenue by Application (2026-2031)
5.2.3 Global Kidney Fibrosis Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Kidney Fibrosis Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck and Co
6.1.1 Merck and Co Company Information
6.1.2 Merck and Co Description and Business Overview
6.1.3 Merck and Co Kidney Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck and Co Kidney Fibrosis Drugs Product Portfolio
6.1.5 Merck and Co Recent Developments/Updates
6.2 Galectin Therapeutics
6.2.1 Galectin Therapeutics Company Information
6.2.2 Galectin Therapeutics Description and Business Overview
6.2.3 Galectin Therapeutics Kidney Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Galectin Therapeutics Kidney Fibrosis Drugs Product Portfolio
6.2.5 Galectin Therapeutics Recent Developments/Updates
6.3 Pfizer Inc
6.3.1 Pfizer Inc Company Information
6.3.2 Pfizer Inc Description and Business Overview
6.3.3 Pfizer Inc Kidney Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pfizer Inc Kidney Fibrosis Drugs Product Portfolio
6.3.5 Pfizer Inc Recent Developments/Updates
6.4 InterMune Inc
6.4.1 InterMune Inc Company Information
6.4.2 InterMune Inc Description and Business Overview
6.4.3 InterMune Inc Kidney Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 InterMune Inc Kidney Fibrosis Drugs Product Portfolio
6.4.5 InterMune Inc Recent Developments/Updates
6.5 La Jolla Pharmaceutical Company
6.5.1 La Jolla Pharmaceutical Company Company Information
6.5.2 La Jolla Pharmaceutical Company Description and Business Overview
6.5.3 La Jolla Pharmaceutical Company Kidney Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 La Jolla Pharmaceutical Company Kidney Fibrosis Drugs Product Portfolio
6.5.5 La Jolla Pharmaceutical Company Recent Developments/Updates
6.6 BioLine Rx
6.6.1 BioLine Rx Company Information
6.6.2 BioLine Rx Description and Business Overview
6.6.3 BioLine Rx Kidney Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 BioLine Rx Kidney Fibrosis Drugs Product Portfolio
6.6.5 BioLine Rx Recent Developments/Updates
6.7 F. Hoffman-La Roche
6.7.1 F. Hoffman-La Roche Company Information
6.7.2 F. Hoffman-La Roche Description and Business Overview
6.7.3 F. Hoffman-La Roche Kidney Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 F. Hoffman-La Roche Kidney Fibrosis Drugs Product Portfolio
6.7.5 F. Hoffman-La Roche Recent Developments/Updates
6.8 ProMetic Life-Sciences Inc
6.8.1 ProMetic Life-Sciences Inc Company Information
6.8.2 ProMetic Life-Sciences Inc Description and Business Overview
6.8.3 ProMetic Life-Sciences Inc Kidney Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 ProMetic Life-Sciences Inc Kidney Fibrosis Drugs Product Portfolio
6.8.5 ProMetic Life-Sciences Inc Recent Developments/Updates
6.9 Genzyme Corporation
6.9.1 Genzyme Corporation Company Information
6.9.2 Genzyme Corporation Description and Business Overview
6.9.3 Genzyme Corporation Kidney Fibrosis Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Genzyme Corporation Kidney Fibrosis Drugs Product Portfolio
6.9.5 Genzyme Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Kidney Fibrosis Drugs Industry Chain Analysis
7.2 Kidney Fibrosis Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Kidney Fibrosis Drugs Production Mode & Process Analysis
7.4 Kidney Fibrosis Drugs Sales and Marketing
7.4.1 Kidney Fibrosis Drugs Sales Channels
7.4.2 Kidney Fibrosis Drugs Distributors
7.5 Kidney Fibrosis Drugs Customer Analysis
8 Kidney Fibrosis Drugs Market Dynamics
8.1 Kidney Fibrosis Drugs Industry Trends
8.2 Kidney Fibrosis Drugs Market Drivers
8.3 Kidney Fibrosis Drugs Market Challenges
8.4 Kidney Fibrosis Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck and Co.
Galectin Therapeutics
Pfizer Inc
InterMune
La Jolla Pharmaceutical Company
F. Hoffman-La Roche
ProMetic Life Sciences Inc
BioLine Rx
Genzyme Corporation
List of Tables
 Table 1. Global Kidney Fibrosis Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Kidney Fibrosis Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Kidney Fibrosis Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Kidney Fibrosis Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Kidney Fibrosis Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Kidney Fibrosis Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Kidney Fibrosis Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Kidney Fibrosis Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Kidney Fibrosis Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Kidney Fibrosis Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Kidney Fibrosis Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Kidney Fibrosis Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Kidney Fibrosis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Fibrosis Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Kidney Fibrosis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Kidney Fibrosis Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Kidney Fibrosis Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Kidney Fibrosis Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Kidney Fibrosis Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Kidney Fibrosis Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Kidney Fibrosis Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Kidney Fibrosis Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Kidney Fibrosis Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Kidney Fibrosis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Kidney Fibrosis Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Kidney Fibrosis Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Kidney Fibrosis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Kidney Fibrosis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Kidney Fibrosis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Kidney Fibrosis Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Kidney Fibrosis Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Kidney Fibrosis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Kidney Fibrosis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Kidney Fibrosis Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Kidney Fibrosis Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Kidney Fibrosis Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Kidney Fibrosis Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Kidney Fibrosis Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Kidney Fibrosis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Kidney Fibrosis Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Kidney Fibrosis Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Kidney Fibrosis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Kidney Fibrosis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Kidney Fibrosis Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Kidney Fibrosis Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Kidney Fibrosis Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Kidney Fibrosis Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Kidney Fibrosis Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Kidney Fibrosis Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Kidney Fibrosis Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Kidney Fibrosis Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Kidney Fibrosis Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Kidney Fibrosis Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Kidney Fibrosis Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Kidney Fibrosis Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Kidney Fibrosis Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Kidney Fibrosis Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Kidney Fibrosis Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Kidney Fibrosis Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Kidney Fibrosis Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Kidney Fibrosis Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Kidney Fibrosis Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Kidney Fibrosis Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Kidney Fibrosis Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Kidney Fibrosis Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Kidney Fibrosis Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Kidney Fibrosis Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Kidney Fibrosis Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck and Co Company Information
 Table 71. Merck and Co Description and Business Overview
 Table 72. Merck and Co Kidney Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck and Co Kidney Fibrosis Drugs Product
 Table 74. Merck and Co Recent Developments/Updates
 Table 75. Galectin Therapeutics Company Information
 Table 76. Galectin Therapeutics Description and Business Overview
 Table 77. Galectin Therapeutics Kidney Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Galectin Therapeutics Kidney Fibrosis Drugs Product
 Table 79. Galectin Therapeutics Recent Developments/Updates
 Table 80. Pfizer Inc Company Information
 Table 81. Pfizer Inc Description and Business Overview
 Table 82. Pfizer Inc Kidney Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pfizer Inc Kidney Fibrosis Drugs Product
 Table 84. Pfizer Inc Recent Developments/Updates
 Table 85. InterMune Inc Company Information
 Table 86. InterMune Inc Description and Business Overview
 Table 87. InterMune Inc Kidney Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. InterMune Inc Kidney Fibrosis Drugs Product
 Table 89. InterMune Inc Recent Developments/Updates
 Table 90. La Jolla Pharmaceutical Company Company Information
 Table 91. La Jolla Pharmaceutical Company Description and Business Overview
 Table 92. La Jolla Pharmaceutical Company Kidney Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. La Jolla Pharmaceutical Company Kidney Fibrosis Drugs Product
 Table 94. La Jolla Pharmaceutical Company Recent Developments/Updates
 Table 95. BioLine Rx Company Information
 Table 96. BioLine Rx Description and Business Overview
 Table 97. BioLine Rx Kidney Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. BioLine Rx Kidney Fibrosis Drugs Product
 Table 99. BioLine Rx Recent Developments/Updates
 Table 100. F. Hoffman-La Roche Company Information
 Table 101. F. Hoffman-La Roche Description and Business Overview
 Table 102. F. Hoffman-La Roche Kidney Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. F. Hoffman-La Roche Kidney Fibrosis Drugs Product
 Table 104. F. Hoffman-La Roche Recent Developments/Updates
 Table 105. ProMetic Life-Sciences Inc Company Information
 Table 106. ProMetic Life-Sciences Inc Description and Business Overview
 Table 107. ProMetic Life-Sciences Inc Kidney Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. ProMetic Life-Sciences Inc Kidney Fibrosis Drugs Product
 Table 109. ProMetic Life-Sciences Inc Recent Developments/Updates
 Table 110. Genzyme Corporation Company Information
 Table 111. Genzyme Corporation Description and Business Overview
 Table 112. Genzyme Corporation Kidney Fibrosis Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Genzyme Corporation Kidney Fibrosis Drugs Product
 Table 114. Genzyme Corporation Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Kidney Fibrosis Drugs Distributors List
 Table 118. Kidney Fibrosis Drugs Customers List
 Table 119. Kidney Fibrosis Drugs Market Trends
 Table 120. Kidney Fibrosis Drugs Market Drivers
 Table 121. Kidney Fibrosis Drugs Market Challenges
 Table 122. Kidney Fibrosis Drugs Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Kidney Fibrosis Drugs
 Figure 2. Global Kidney Fibrosis Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Kidney Fibrosis Drugs Market Share by Type: 2024 & 2031
 Figure 4. Angiotensin Converting Enzyme (ACE) Inhibitors Product Picture
 Figure 5. Pirfenidone Product Picture
 Figure 6. Renin Inhibitors Product Picture
 Figure 7. Angiotensin II Receptor Blockers (ARBs) Product Picture
 Figure 8. Vasopeptidase Inhibitors Product Picture
 Figure 9. Global Kidney Fibrosis Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Kidney Fibrosis Drugs Market Share by Application: 2024 & 2031
 Figure 11. Chronic Kidney Diseases
 Figure 12. Kidney Cancer Treatment
 Figure 13. Others
 Figure 14. Global Kidney Fibrosis Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Kidney Fibrosis Drugs Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Kidney Fibrosis Drugs Sales (2020-2031) & (K Units)
 Figure 17. Global Kidney Fibrosis Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 18. Kidney Fibrosis Drugs Report Years Considered
 Figure 19. Kidney Fibrosis Drugs Sales Share by Manufacturers in 2024
 Figure 20. Global Kidney Fibrosis Drugs Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Kidney Fibrosis Drugs Players: Market Share by Revenue in Kidney Fibrosis Drugs in 2024
 Figure 22. Kidney Fibrosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Kidney Fibrosis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Kidney Fibrosis Drugs Sales Market Share by Country (2020-2031)
 Figure 25. North America Kidney Fibrosis Drugs Revenue Market Share by Country (2020-2031)
 Figure 26. United States Kidney Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Kidney Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Kidney Fibrosis Drugs Sales Market Share by Country (2020-2031)
 Figure 29. Europe Kidney Fibrosis Drugs Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Kidney Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Kidney Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Kidney Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Kidney Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Kidney Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Kidney Fibrosis Drugs Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Kidney Fibrosis Drugs Revenue Market Share by Region (2020-2031)
 Figure 37. China Kidney Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Kidney Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Kidney Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Kidney Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Kidney Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Kidney Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Kidney Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Kidney Fibrosis Drugs Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Kidney Fibrosis Drugs Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Kidney Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Kidney Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Kidney Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Kidney Fibrosis Drugs Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Kidney Fibrosis Drugs Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Kidney Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Kidney Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Kidney Fibrosis Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Kidney Fibrosis Drugs by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Kidney Fibrosis Drugs by Type (2020-2031)
 Figure 56. Global Kidney Fibrosis Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Kidney Fibrosis Drugs by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Kidney Fibrosis Drugs by Application (2020-2031)
 Figure 59. Global Kidney Fibrosis Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 60. Kidney Fibrosis Drugs Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Renal Disease Treatment Market Research Report 2024
Global Chronic Kidney Disease Drugs Market Research Report 2025
Rare Kidney Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Idiopathic Pulmonary Fibrosis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Complement Drug for Kidney Disease Market Research Report 2024
Polycystic Kidney Disease Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Kidney Cancer Diagnosis Market Research Report 2025
Acute Kidney Injury Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Kidney Cancer Targeted Therapy Market Research Report 2025
Global Drugs for Retroperitoneal Fibrosis Market Research Report 2024
Global Polycystic Kidney Disease Treatment Market Research Report 2025
Global Renal Anemia Therapeutics Market Research Report 2025
Urinary Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Continuous Renal Replacement Therapy Market Research Report 2024
Pharmaceutical Retail Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Acquired Cystic Kidney Disease Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Idiopathic Pulmonary Fibrosis Drug Market Research Report 2025
Urinary System Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Kidney Fibrosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions